Divi's Laboratories Ltd. | Large-cap | Healthcare
₹6,616.00
0.45%
| Divi's Laboratories Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 93.6B
Gross Profit 56.4B 60.20%
Operating Income 25.7B 27.41%
Net Income 21.9B 23.41%
EPS (Diluted) ₹82.53

Balance Sheet Metrics

Total Assets 169.3B
Total Liabilities 19.6B
Shareholders Equity 149.7B
Debt to Equity 0.13

Cash Flow Metrics

Operating Cash Flow 19.7B
Free Cash Flow 2.2B

Revenue & Profitability Trend

Divi's Laboratories Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 93.6B 78.0B 76.6B 88.0B 68.6B
Cost of Goods Sold 37.2B 32.7B 31.8B 30.9B 24.3B
Gross Profit 56.4B 45.3B 44.9B 57.1B 44.3B
Operating Expenses 14.2B 12.6B 12.3B 10.2B 8.3B
Operating Income 25.7B 18.3B 20.3B 35.7B 26.2B
Pre-tax Income 29.2B 21.6B 23.7B 36.8B 26.7B
Income Tax 7.2B 5.6B 5.4B 7.2B 6.8B
Net Income 21.9B 16.0B 18.2B 29.6B 19.8B
EPS (Diluted) ₹82.53 ₹60.27 ₹68.69 ₹111.52 ₹74.75

Income Statement Trend

Divi's Laboratories Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 100.8B 96.8B 93.1B 83.5B 61.7B
Non-Current Assets 68.5B 58.0B 51.3B 50.2B 46.0B
Total Assets 169.3B 154.7B 144.4B 133.7B 107.7B
Liabilities
Current Liabilities 14.5B 12.8B 11.0B 12.0B 11.1B
Non-Current Liabilities 5.1B 6.2B 5.7B 4.5B 3.7B
Total Liabilities 19.6B 19.0B 16.7B 16.5B 14.8B
Equity
Total Shareholders Equity 149.7B 135.7B 127.7B 117.3B 92.9B

Balance Sheet Composition

Divi's Laboratories Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 29.2B 21.6B 23.7B 36.8B 26.7B
Operating Cash Flow 19.7B 11.9B 26.1B 22.0B 21.7B
Investing Activities
Capital Expenditures -14.4B -10.0B -4.7B -7.1B -9.1B
Investing Cash Flow -11.0B -5.7B -29.1B -22.6B 181.2M
Financing Activities
Dividends Paid -8.0B -8.0B -8.0B -5.3B -
Financing Cash Flow -8.0B -8.0B -8.0B -5.3B -665.6M
Free Cash Flow 2.2B 2.6B 19.9B 12.0B 10.4B

Cash Flow Trend

Divi's Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 80.53
Forward P/E 117.87
Price to Book 11.77
Price to Sales 18.82
PEG Ratio 117.87

Profitability Ratios

Profit Margin 23.41%
Operating Margin 30.14%
Return on Equity 15.35%
Return on Assets 9.90%

Financial Health

Current Ratio 6.94
Debt to Equity 0.03
Beta 0.34

Per Share Data

EPS (TTM) ₹82.40
Book Value per Share ₹563.71
Revenue per Share ₹352.57

Financial data is updated regularly. All figures are in the company's reporting currency.